Impax Labs will collaborate with Banner Pharmacaps Inc. with
respect to the supply and commercialization of two softgel capsule products.
The products and terms of the agreement were not disclosed.
Larry Hsu, Ph.D., president and CEO of Impax Laboratories,
said: “We are excited to collaborate with Banner, a global leader in
developing and manufacturing softgel products. In less than a year, we have entered
into four distinct partnerships for alternate dosage form products as we
continue to execute our strategy of diversifying our product base. Our business
development activities will continue to focus on delivering growth from
high-value products, technologies, and businesses in complementary dosage
forms.” Roger E. Gordon, Ph.D., president and CEO of Banner Pharmacaps
Inc., added: “We are delighted to be joining forces with Impax, a specialty
pharmaceutical company whose vision and goals so closely mirror those of
Banner. They join our expanding list of partners who look to Banner to provide
expertise in the development of gelatin-based drug delivery systems and unique
technology platforms.”
